Dr. Schwarzenberger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
666 3rd Ave FL 28
New York, NY 10017Phone+1 504-444-7902Fax+1 504-444-7902
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1990 - 1992
Methodist Le Bonheur Healthcare/CentralInternship, Internal Medicine, 1989 - 1990
University of Wurzburg Faculty of MedicineClass of 1987
Certifications & Licensure
NY State Medical License 2012 - 2025
LA State Medical License 1995 - 2019
FL State Medical License Active through 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma Start of enrollment: 1997 Aug 01
- Once Weekly Radiation for Lung Cancer With Chemotherapy Start of enrollment: 2002 Sep 01
- Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study Start of enrollment: 2003 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 117 citationsPembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.Silvia Novello, Dariusz M Kowalski, Alexander Luft, Mahmut Gümüş, David Vicente
Journal of Clinical Oncology. 2023-04-10 - 139 citationsPembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.Marina C Garassino, Shirish Gadgeel, Giovanna Speranza, Enriqueta Felip, Emilio Esteban
Journal of Clinical Oncology. 2023-04-10 - 4 citationsFirst-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices.Stephen V Liu, Pragya Rai, Dong Wang, Xiaohan Hu, Paul Otto Schwarzenberger
JTO Clinical and Research Reports. 2023-02-01
Grant Support
- The Gulf Coast MbccopNational Cancer Institute2007
- Gulf Coast MbccopNational Cancer Institute2005–2007
- IL-17 And HematopoiesisNational Cancer Institute2006
- Treatment Protocol For Allovectin-7 In Metastatic Cancer By Direct Gene TransferNational Center For Research Resources2005–2006
- Investigation Of Cross Immunity Following Vaccination With Allogenic Cancer CellNational Center For Research Resources2005–2006
- Combination Of Weekly Chest Radiotherapy And Oral Navelbine For NsclcNational Center For Research Resources2005–2006
- Combination Of Weekly Radiation And Docetaxel For Locally Advanced NON Small CANational Center For Research Resources2004–2006
- IL-17 And HematopoiesisNational Cancer Institute1999–2005
- Combination Of Weekly Chest Radiotherapy &Oral NavelbineNational Center For Research Resources2004
- Minority Based Community Clinical Oncology ProgramNational Cancer Institute2003
- Radiation And Doxetaxel For NsclcNational Center For Research Resources2000–2001
- Gene Transfer Of HLA-B7 In MelanomaNational Center For Research Resources2000–2001
- Dacarbazine/Allovectin-7 In Metastatic MelanomaNational Center For Research Resources2000–2001
- Treatment Of Malignant Pleural Mesothelioma W/ Gene Modified Cancer Cell LinesNational Center For Research Resources1998–2001
- Trial Of Bryostatin/Il-2 To Enhance Antigen PresentationNational Cancer Institute2000
- Phase I/11 Pilot Study Of KW2189 For Pancreatic CarcinomaNational Center For Research Resources1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
